Trials / Sponsors / OriCell Therapeutics Co., Ltd.
OriCell Therapeutics Co., Ltd.
Industry · 3 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study Neoplasms, Plasma Cell, Neoplasms by Histologic Type, Neoplasms | Phase 1 | 2024-04-03 |
| Recruiting | OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMM Relapsed and/or Refractory Multiple Myeloma | Phase 1 / Phase 2 | 2023-10-26 |
| Recruiting | Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2022-12-15 |